Viropro Stock

Viropro EBIT

The EBIT of Viropro (VPRO) as of Aug 9, 2026 is -996,515.00 USD.

EBIT

-996,515.00USD

Last updated:

In 2026, Viropro's EBIT was -996,515.00 USD, a % increase from the - USD EBIT recorded in the previous year.

The Viropro EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (undefined USD)
Date
EBIT (undefined USD)
Jan 1, 2007
0.00 base
Jan 1, 2008
0.00 base
Jan 1, 2009
0.00 base
Jan 1, 2010
0.00 base
YEAREBIT (undefined USD)
2010 -
2009 -
2008 -
2007 -
Access this data via the Eulerpool API

Viropro Revenue

Viropro Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2007
264,000.00 USD
-1.78 M USD
-2.66 M USD
Jan 1, 2008
0.00 USD
-852,797.00 USD
-1.73 M USD
Jan 1, 2009
0.00 USD
-879,513.00 USD
-1.46 M USD
Jan 1, 2010
571,098.00 USD
-996,515.00 USD
-1.01 M USD

Viropro Margins

Viropro stock margins

The Viropro margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Viropro. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Viropro.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2007
100.00 %
-672.73 %
-1,005.68 %
Jan 1, 2008
100.00 %
- %
- %
Jan 1, 2009
100.00 %
- %
- %
Jan 1, 2010
100.00 %
-174.49 %
-176.88 %

Viropro Stock analysis

What does Viropro do? Viropro Inc. is a pharmaceutical company specializing in the use of technologies for the production of biopharmaceutical products. Founded in 2004, the company aims to develop innovative and effective solutions for medical niche areas. The company is based in Canada and also has locations in Europe and Asia. With over 100 employees worldwide, Viropro offers a wide range of laboratory services to develop effective and safe medications. Viropro relies on a unique business model that utilizes cell culture technologies and bioreactors. They utilize a highly specialized cell preparation technology called "VIPER" which ensures the production of recombinant proteins and antibodies of the highest quality. Partnerships with other pharmaceutical and biotechnology companies are also an important aspect of Viropro's business model. They work with many companies to develop and bring medications to the market. Viropro's business activities extend to several areas within the bioproduct sector. However, the core element is the antibodies that the company produces and markets. Viropro's products also include human antibodies against cancer, HIV, and other serious diseases. Their portfolio also includes pharmacokinetic studies, antigen and peptide design services, as well as cell preparation and culture processing services. With a wide range of services and products, the company is able to develop customized solutions for the specific needs of its customers. In the field of cell preparation, Viropro primarily offers laboratory services that include a wide range of equipment and associated technologies. The VIPER technology developed by Viropro is a core component of this business unit. The peptide and antigen design unit offers services that focus on the identification and optimization of antibodies and peptides. The latest computer-based methods are used to simulate how certain proteins can develop on the computer. These methods are particularly effective in developing antibody-based medications. Finally, Viropro also offers pharmacokinetic services to ensure the safety and effectiveness of medications, as well as proper administration and dosage. Although the company is still relatively young, Viropro already has an impressive track record in the development and marketing of bioproducts. The company has brought several antibodies to the market and is contributing to providing lifesaving therapies for some of the most serious health problems of our time. Overall, Viropro is an exciting biotechnology company operating in a rapidly growing market and tackling some of the most important therapeutic challenges of our time. With the combination of innovative technologies and a flexible business model, the company is well-positioned to continue playing a leading role in the pharmaceutical and biotechnology industry. Viropro is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Viropro's EBIT

Viropro's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Viropro's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Viropro's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Viropro’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Viropro stock

EBIT of Viropro is -996,515.00 USD in 2026.

On Eulerpool you can find the complete historical development of EBIT Viropro since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Viropro historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Viropro

All Key Metrics — Viropro